60
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation

, , , , , , , , , , , , , & show all
Pages 677-686 | Published online: 16 Feb 2016

References

  • SaravananPDavidsonNCRisk assessment for sudden cardiac death in dialysis patientsCirc Arrhythm Electrophysiol20103555355920959609
  • PedersenCTKayGNKalmanJEHRA/HRS/APHRS expert consensus on ventricular arrhythmiasHeart Rhythm20141110166196
  • JanuaryCTWannLSAlpertJS2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm SocietyJ Am Coll Cardiol2014642117624998121
  • JenningsDLMartinezBMontalvoSLanfearDEImpact of pre-implant amiodarone exposure on outcomes in cardiac transplant recipientsHeart Fail Rev201520557357825925244
  • ChinCFeindelCChengDDuration of preoperative amiodarone treatment may be associated with postoperative hospital mortality in patients undergoing heart transplantationJ Cardiothorac Vasc Anesth199913556256610527225
  • LatiniRTognoniGKatesREClinical pharmacokinetics of amiodaroneClin Pharmacokinet1984921361566370540
  • ZipesDPPrystowskyENHegerJJAmiodarone: electrophysiologic actions, pharmacokinetics and clinical effectsJ Am Coll Cardiol198434105910716368644
  • SomaniPBasic and clinical pharmacology of amiodarone: relationship of antiarrhythmic effects, dose and drug concentrations to intracellular inclusion bodiesJ Clin Pharmacol19892954054122544634
  • DoeschAOMüllerSKonstandinMMalignancies after heart transplantation: incidence, risk factors, and effects of calcineurin inhibitor withdrawalTransplant Proc20104293694369921094840
  • RiviniusRHelmschrottMRuhparwarAAnalysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapyDrug Des Devel Ther2014993102
  • HelmschrottMBeckendorfJAkyolCSuperior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimenDrug Des Devel Ther2014813071314
  • HelmschrottMRiviniusRRuhparwarAAdvantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantationDrug Des Devel Ther2015912171224
  • MacdonaldPHackworthyRKeoghASivathasanCChangVSprattPThe effect of chronic amiodarone therapy before transplantation on early cardiac allograft functionJ Heart Lung Transplant1991107437491958681
  • Chelimsky-FallickCMiddlekauffHRStevensonWGAmiodarone therapy does not compromise subsequent heart transplantationJ Am Coll Cardiol1992207155615611452930
  • KonertzWWeyandMDeiwickMScheldHHIs pretransplant anti-arrhythmic drug therapy a risk factor?Transplant Proc1992246267726781465898
  • BlombergPJFeingoldADDenofrioDComparison of survival and other complications after heart transplantation in patients taking amiodarone before surgery versus those not taking amiodaroneAm J Cardiol200493337938114759399
  • Sanchez-LazaroIJAlmenarLMartinez-DolzLDoes amiodarone influence early mortality in heart transplantation?Transplant Proc20063882537253817097993
  • YerebakanHNakaYSorabellaRAmiodarone treatment prior to heart transplantation is associated with acute graft dysfunction and early mortality: a propensity-matched comparisonJ Heart Lung Transplant2014334S105
  • GiardinaEGSchneiderMBarrMLMyocardial amiodarone and desethylamiodarone concentrations in patients undergoing cardiac transplantationJ Am Coll Cardiol19901649439472212375
  • KarimiSHoughABeckeyCParraDResults of a safety initiative for patients on concomitant amiodarone and simvastatin therapy in a Veterans Affairs medical centerJ Manag Care Pharm201016747248120726676
  • BourgeRCNaftelDCCostanzo-NordinMRPretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database GroupJ Heart Lung Transplant19931245495628369318
  • ScottCDDarkJHMcCombJMArrhythmias after cardiac transplantationAm J Cardiol19927011106110631384302
  • BertoletBDEagleDAContiJBMillsRMBelardinelliLBradycardia after heart transplantation: reversal with theophyllineJ Am Coll Cardiol19962823963998800116
  • DiBiaseATseTMSchnittgerIWexlerLStinsonEBValantineHAFrequency and mechanism of bradycardia in cardiac transplant recipients and need for pacemakersAm J Cardiol19916716138513892042569
  • DasariTWPavlovic-SurjancevBPatelNIncidence, risk factors, and clinical outcomes of atrial fibrillation and atrial flutter after heart transplantationAm J Cardiol2010106573774120723655
  • PavriBBO’NunainSSNewellJBRuskinJNWilliamGPrevalence and prognostic significance of atrial arrhythmias after orthotopic cardiac transplantationJ Am Coll Cardiol1995257167316807759722
  • HohnloserSHPajitnevDPogueJIncidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W SubstudyJ Am Coll Cardiol200750222156216118036454
  • AhmariSABunchTJChandraAPrevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutterJ Heart Lung Transplant2006251536016399531